1. [IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology].
- Author
-
Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, Lottenberg AM, Chacra AP, Faludi AA, Loures-Vale AA, Carvalho AC, Duncan B, Gelonese B, Polanczyk C, Rodrigues Sobrinho CR, Scherr C, Karla C, Armaganijan D, Moriguchi E, Saraiva F, Pichetti G, Xavier HT, Chaves H, Borges JL, Diament J, Guimarães JI, Nicolau JC, dos Santos JE, de Lima JJ, Vieira JL, Novazzi JP, Faria Neto JR, Torres KP, Pinto Lde A, Bricarello L, Bodanese LC, Introcaso L, Malachias MV, Izar MC, Magalhães ME, Schmidt MI, Scartezini M, Nobre M, Foppa M, Forti NA, Berwanger O, Gebara OC, Coelho OR, Maranhão RC, dos Santos Filho RD, Costa RP, Barreto S, Kaiser S, Ihara S, Carvalho Td, Martinez TL, Relvas WG, and Salgado W
- Subjects
- Adult, Age Distribution, Aged, Cholesterol blood, Clofibric Acid therapeutic use, Coronary Artery Disease etiology, Coronary Artery Disease physiopathology, Diet, Female, Humans, Hyperlipidemias complications, Hyperlipidemias physiopathology, Hypolipidemic Agents therapeutic use, Lipid Metabolism drug effects, Male, Metabolic Syndrome complications, Middle Aged, Naphthalenes therapeutic use, Risk Factors, Sex Distribution, Smoking adverse effects, Triglycerides blood, Coronary Artery Disease prevention & control, Hyperlipidemias therapy, Lipid Metabolism physiology
- Published
- 2007
- Full Text
- View/download PDF